Singapore markets open in 3 hours 34 minutes
Straits Times Index
3,264.53 -35.51 (-1.08%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
61,409.41 -1,696.48 (-2.69%) CMC Crypto 200
1,307.04 +12.37 (+0.96%)
Viking Therapeutics Inc (1VT.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 08:30PM CEST
| Previous close | 73.38 |
| Open | 74.22 |
| Bid | 73.98 x 0 |
| Ask | 74.56 x 0 |
| Day's range | 72.10 - 74.52 |
| 52-week range | 8.29 - 90.40 |
| Volume | |
| Avg. volume | 20 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company
Key Insights Significantly high institutional ownership implies Viking Therapeutics' stock price is sensitive to their...
Insider MonkeyViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
- Thomson Reuters StreetEvents
Q1 2024 Viking Therapeutics Inc Earnings Call
Q1 2024 Viking Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.